Prokaryotics
Business Services · New Jersey, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1075 Morris Ave Ste 5-19, Union, New Jer...Phone Number
+1 9087371922 ext. 124Website
www.prokaryotics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Prokaryotics
Prokaryotics Inc. is an antibacterial discovery organization focused on developing innovative therapeutics to combat multidrug resistant bacteria and the global crisis of antibiotic resistance. The company, formed by former senior scientists from Merck & Co., Inc., has secured worldwide rights to develop and commercialize pre-clinical assets targeting both Gram-negative and Gram-positive bacteria. Prokaryotics aims to leverage its expertise in bacterial physiology and medicinal chemistry to create new classes of antibiotics that target bacterial cell envelope assembly. Their programs are designed to address the urgent need for effective treatments against antibiotic-resistant infections.Explore more
Prokaryotics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Prokaryotics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Prokaryotics, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Prokaryotics had a recent Job posting/layoffs
Product Launch: Get notified when Prokaryotics launches new products
Check if Prokaryotics has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Prokaryotics has new funding data
Congratulate Masked Content for being promoted to Masked Content at Prokaryotics
Earning: See what the market has to say on Prokaryotics recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Prokaryotics is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Prokaryotics as Masked Content
Find 2 more new buyers
Compare Similar Companies to Prokaryotics
Compare insights from companies similar to Prokaryotics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Prokaryotics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Prokaryotics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Prokaryotics.
Prokaryotics Tech Stack
A closer look at the technologies used by Prokaryotics
Prokaryotics News & Media
Prokaryotics Announces Licensing Agreement with Northern Antibiotics for Novel Gram-negative Antibiotic Potentiator
UNION, N.J., June 26, 2025 /PRNewswire/ -- Prokaryotics Inc., a privately-held biopharmaceutical company engaged in the discovery and development of novel anti-infective drugs, announced today that it has entered into a licensing agreement with Northern Antibiotics on June 4, 2025. As...Prokaryotics Receives $2.3 Million SBIR Award Supporting Its Immune Potentiation Program and Advances Two Additional SBIR-funded Antibiotic Programs into Phase 2 Lead Optimization
UNION, N.J., Aug. 1, 2019 /PRNewswire/ -- Prokaryotics, Inc., a privately-held biopharmaceutical company engaged in the discovery and development of novel anti-infective drugs, announced today that it has been awarded its third Small Business Innovation Research (SBIR) grant valued at up...Prokaryotics Receives $2.3M SBIR Grant
Prokaryotics, Inc., a Union, N.J.-based biopharmaceutical company engaged in the discovery and development of novel anti-infective drugs, has been awarded its second Small Business Innovation Research Grant (SBIR) valued at up to $2.3m. The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) provided the award. The two-year agreement […] The post Prokaryotics Receives $2.3M SBIR Grant appeared first on FinSMEs.Prokaryotics Receives $2.3 Million SBIR Grant Supporting A Second Novel Antibiotic Program
UNION, N.J., Sept. 13, 2018 /PRNewswire/ -- Prokaryotics, Inc., a privately-held biopharmaceutical company engaged in the discovery and development of novel anti-infective drugs, announced today that it has been awarded its second Small Business Innovation Research Grant (SBIR) valued at...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Prokaryotics
Sign Up For FreeTo access detailed company insights
Prokaryotics Inc. is an antibacterial discovery organization focused on developing innovative therapeutics to combat multidrug resistant bacteria and the global crisis of antibiotic resistance. The company, formed by former senior scientists from Merck & Co., Inc., has secured worldwide rights to develop and commercialize pre-clinical assets target... Read More
